Regulus Therapeutics (RGLS) Misses Q1 EPS by 3c, Announces Workforce Reduction; CEO to Resign

Go back to Regulus Therapeutics (RGLS) Misses Q1 EPS by 3c, Announces Workforce Reduction; CEO to Resign

Regulus Therapeutics (RGLS) Halted, News Pending

May 4, 2017 4:23 PM EDT

Regulus Therapeutics (NASDAQ: RGLS) Halted, News Pending

... More